Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Seppo Auriola"'
Autor:
Loes F. S. Kooreman, Niina Saarinen, Bert Delvoux, Florian Caiment, Youssef Walid, Seppo Auriola, Roy F.P.M. Kruitwagen, Natasja G. Lieuwes, Andrea Romano, Sofia Xanthoulea, Gonda Konings, Pasi Koskimies, Merja R. Häkkinen, Frank Verhaegen, Elisabetta d'Avanzo
Publikováno v:
Cancer Research. 81:2931-2931
Endometrial cancer (EC) is the most common gynaecological tumor in developed countries and its incidence is increasing. Approximately 80% of newly diagnosed EC cases are estrogen-dependent. Type 1 17β-hydroxysteroid dehydrogenase (17β-HSD-1) is the
Publikováno v:
Cancer Research. 79:3293-3293
Prostate cancer patients using cholesterol-lowering statins have 30 % lower risk of prostate cancer death compared to non-users. The effect is attributed to the inhibition of the mevalonate pathway which is active in prostate cancer cells. Statin int
Autor:
Tero Aittokallio, Matias Knuuttila, Teemu D. Laajala, Sari Mäkelä, Seppo Auriola, Merja R. Häkkinen, Jenny Kallio, Saija Savolainen, Matti Poutanen, Pekka Keski-Rahkonen, Riikka Oksala, Emrah Yatkin
Publikováno v:
Cancer Research. 74:LB-31
Androgens are key factors involved in the development and progression of prostate cancer (PCa), and the growth of PCa can be suppressed by androgen deprivation therapy (ADT). In a significant proportion of men receiving ADT, PCa progresses to castrat
Autor:
Terho Lehtimäki, Antti Kaipia, Teemu Tolonen, Heimo Syvala, Seppo Auriola, Teemu J. Murtola, Juha Koskimaki, Emma Raitoharju, Teuvo Tammela, Paula Kujala, Jarno Riikonen
Publikováno v:
Cancer Prevention Research. 5:B69-B69
Background: A widely used group of cholesterol-lowering drugs, statins, have shown promise in prostate cancer prevention. Statin treatment inhibits growth of prostate cancer cells. Statin users have decreased risk of advanced prostate cancer and poss